ReviewDiabetology & metabolic syndrome2025
Low fat-diet and circulating adipokines concentrations: a systematic review and meta-analysis of randomized controlled trials.
Review in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Secretion Patterns of Leptin: A Key Component in the Regulation of Energy Homeostasis and Its Therapeutic Applications.Biomolecules · 2026Review
- Impact of Nutrition on Somatotroph Axis: A Potential Role in Acromegaly and Its Cardiovascular Risk?Journal of the Endocrine Society · 2026Review
- Organokine-Mediated Crosstalk: A Systems Biology Perspective on the Pathogenesis of MASLD-A Narrative Review.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLow-fat diets have gained considerable attention in the management of obesity. The present meta-analysis evaluated randomized controlled trials (RCTs) to determine whether adults adhering to low-fat diets (≤ 30% of total energy intake) experience more significant changes in serum adipokine levels compared to those following high-fat diets. MAIN TEXT: A comprehensive search was conducted in PubMed, Scopus, Web of Science, and CENTRAL for eligible RCTs up to February 4, 2025. Weighted mean differences (WMD) were calculated and pooled using a random-effects model. Forty-eight trials were included in this study. The meta-analysis found no significant effects of low-fat diets on serum leptin (WMD = 0.06 ng/ml; 95% CI: -0.33, 0.45; P = 0.76; I² = 64.57%), resistin (WMD = -0.67 ng/ml; 95% CI: -1.52, 0.17; P = 0.12; I² = 86.53%), or adiponectin (WMD = 0.07 ng/ml; 95% CI: -0.29, 0.43; P = 0.76; I² = 90.29%). Subgroup analysis showed a significant decrease in adiponectin levels among females (n = 4; WMD = -0.47 ng/ml; P = 0.02; I² = 0%). However, low-fat diets with higher protein content increased adiponectin levels (n = 3; WMD = 1.78 ng/ml; P < 0.001; I² = 0%). Sensitivity analysis revealed that excluding the study by Heggen et al. (2012) resulted in a significant reduction in serum resistin levels (WMD = -0.93 ng/ml; P = 0.04; I² = 86.9%).
conclusionsLow-fat diets may have beneficial effects on resistin levels. Additionally, low-fat diets with higher protein content may increase adiponectin levels. However, due to the uncertainty of the available evidence, firm conclusions cannot be drawn. Further high-quality research is needed to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.